FDA issues warning on Medline fluid delivery sets over potential high-risk issue

The FDA has issued an early warning regarding Medline Fluid Delivery Sets, which may pose a significant health risk due to a potentially incorrect assembly, according to a Dec. 30 news release from the agency. 

Advertisement

The issue involves Fluid Delivery Sets with a white macro drip chamber, which were mistakenly included in some kits instead of the required grey micro drip chamber. The macro chip chamber delivers fluid at a rate three times higher than the micro drip chamber, increasing the risk of over-administration. 

The FDA has flagged this as a potentially high-risk issue, as improper fluid delivery can lead to serious complications such as edema, shortness of breath, high blood pressure and in severe cases, death. 

Medline has already notified healthcare providers, urging them to check their stock, identify the incorrect sets and discard any containing the white macro drip chamber. Products with the correct grey micro drip chamber can still be safely used. 

While Medline has not reported any injuries, the FDA is closely monitoring the situation. 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.